Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
Open Access
- 22 May 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (10), 3664
- https://doi.org/10.3390/ijms21103664
Abstract
Pantothenate Kinase-associated Neurodegeneration (PKAN) belongs to a wide spectrum of diseases characterized by brain iron accumulation and extrapyramidal motor signs. PKAN is caused by mutations in PANK2, encoding the mitochondrial pantothenate kinase 2, which is the first enzyme of the biosynthesis of Coenzyme A. We established and characterized glutamatergic neurons starting from previously developed PKAN Induced Pluripotent Stem Cells (iPSCs). Results obtained by inductively coupled plasma mass spectrometry indicated a higher amount of total cellular iron in PKAN glutamatergic neurons with respect to controls. PKAN glutamatergic neurons, analyzed by electron microscopy, exhibited electron dense aggregates in mitochondria that were identified as granules containing calcium phosphate. Calcium homeostasis resulted compromised in neurons, as verified by monitoring the activity of calcium-dependent enzyme calpain1, calcium imaging and voltage dependent calcium currents. Notably, the presence of calcification in the internal globus pallidus was confirmed in seven out of 15 genetically defined PKAN patients for whom brain CT scan was available. Moreover, we observed a higher prevalence of brain calcification in females. Our data prove that high amount of iron coexists with an impairment of cytosolic calcium in PKAN glutamatergic neurons, indicating both, iron and calcium dys-homeostasis, as actors in pathogenesis of the disease.This publication has 35 references indexed in Scilit:
- Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron DepositionPharmaceuticals, 2019
- Neurodegeneration with brain iron accumulationPublished by Elsevier BV ,2018
- Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)Molecular Genetics and Metabolism, 2017
- Neurodegeneration with Brain Iron AccumulationCurrent Neurology and Neuroscience Reports, 2016
- Compartmentalization of Mammalian Pantothenate KinasesPLOS ONE, 2012
- Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse modelHuman Molecular Genetics, 2012
- Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulationAnnals of Neurology, 2006
- Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2Journal of Neuroscience, 2005
- Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz SyndromeThe New England Journal of Medicine, 2003
- A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndromeNature Genetics, 2001